Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
2023 Global Forecast for Proliferative Diabetic Retinopathy Therapeutics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
KALYDECO Drug Insight and Market Forecast − 2032
... KALYDECO for cystic fibrosis in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom for the study period 2019 –2032 is provided in this report along with a ... Read More
-
Oral Proteins and Peptides Market (4th Edition) by Target Disease Indication (acromegaly, celiac disease, chronic idiopathic constipation, enteric hyperoxaluria, inflammatory bowel disease and type II diabetes), Type of Molecule (protein and peptide), Technology Platforms, Biological Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others) Key Players and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032
... Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others) Key Players and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032 INTRODUCTION Since the approval of the ... Read More
-
Site Management Organizations Market by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phase (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035
... Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035 Clinical trials form an integral ... Read More
-
Epilepsy
... can occur in people, and the severity and symptoms of epilepsy may vary from person to person. Some people may experience infrequent seizures that are well controlled by medication while others may experience severe and ... Read More
-
2023 Global Forecast for Plasma Therapeutics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2024 ... Read More
-
Opioid Use Disorder (OUD) - Epidemiology Forecast–2032
... opioid tolerance, and withdrawal syndrome when discontinued. In 2022, the highest number of diagnosed prevalent cases of Opioid Use Disorder (OUD) was observed in the United States among the 7MM. As per severity-specific cases, it ... Read More
-
2023 Global Forecast for Parkinson'S Disease (Pd) Drugs Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Sarcopenia- Pipeline Insight, 2023
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Sarcopenia: Understanding Sarcopenia: Overview ... Read More
-
Fibromyalgia- Pipeline Insight, 2023
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Fibromyalgia: Understanding Fibromyalgia: Overview ... Read More
-
Batten Disease- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Batten ... Read More
-
Chondrosarcoma - Epidemiology Forecast - 2032
... cancer cases. Several histological subtypes of chondrosarcoma have been described, including conventional, dedifferentiated, mesenchymal, and clear-cell Chondrosarcoma. Conventional chondrosarcomas represent ~85% of all chondrosarcomas and can be categorized according to their location in bone into ... Read More
-
Obsessive-Compulsive Disorder - Market Insight, Epidemiology And Market Forecast - 2032
... largely the same as in DSM-IV, requiring either obsessions or compulsions. The major change in the DSM-5 criteria for OCD is the addition of two specifiers for this diagnosis: insight and tic-related disorder. OCD symptoms ... Read More
-
Trigeminal Neuralgia- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Trigeminal ... Read More
-
Idiopathic Membranous Nephropathy (IMN) – Market Insights, Epidemiology and Market Forecast – 2032
... abnormal kidney function, and swelling. It is also called membranous glomerulopathy. MN is a rare disease affecting the kidney glomerulus, specifically the podocytes, which are key in controlling the kidney’s permeability to proteins. Albumin and ... Read More
-
Lymphoedema- Pipeline Insight, 2023
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Lymphoedema: Understanding Lymphoedema: Overview ... Read More
-
Scleroderma- Pipeline Insight, 2023
... products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Scleroderma: Understanding Scleroderma: Overview ... Read More
-
Neutropenia - Pipeline Insight, 2023
... stage products. It also covers the therapeutics assessment by product type, stage, route of admin istration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Neutropenia: Understanding ... Read More
-
PEComa – Market Insights, Epidemiology and Market Forecast – 2032
... further expected to increase by 2032. The total number of incident cases of PEComa in the United States was around 250 cases in 2022 and are projected to increase during the forecasted period (2023-2032). Aadi ... Read More
-
Meibomian Gland Dysfunction- Pipeline Insight, 2023
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Graves' Disease
... includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable targets • ... Read More
-
AI-Enabled Drug Discovery and Clinical Trials Market Report 2023-2033
... to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Growing Awareness ... Read More
-
Emerging Landscape of Targeted Protein Degradation Therapeutics
... enable treating various diseases not yet treatable via conventional approaches by attacking disease-causing proteins in a controlled manner, thus reducing the risk of side effects. It is estimated that 80% of a cell’s proteome cannot ... Read More
-
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics
... significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening and easing ... Read More